Anti-Myeloma Effects of the Selective JAK1 Inhibitor INCB052793 in Combination with Active Myeloma Agents In Vitro and In Vivo

被引：0

作者：

Sanchez, Eric ^{[1
]}

Porter, Autumn ^{[2
]}

Li, Mingjie ^{[1
]}

Wang, Cathy ^{[1
]}

Smith, Emily ^{[2
]}

Soof, Camilia ^{[1
]}

Director, Chelsea ^{[2
]}

Tang, George ^{[1
]}

Chen, Haiming ^{[1
]}

Berenson, James ^{[1
]}

机构：

[1] Inst Myeloma & Bone Canc Res, West Hollywood, CA USA

[2] Inst Myeloma & Bone Canc Res, Hollywood, CA USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期

关键词：

D O I：

10.1016/j.clml.2017.03.089

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PS-087 (d)

引用

页码：E49 / E50

页数：2

共 50 条

[1] The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo
Sanchez, Eric
Li, Mingjie
Patil, Saurabh
Soof, Camilia M.
Nosrati, Jason D.
Schlossberg, Remy E.
Vidisheva, Aleksandra
Tanenbaum, Edward J.
Hekmati, Tara
Zahab, Brian
Wang, Cathy
Tang, George
Chen, Haiming
Berenson, James R.
[J]. ANNALS OF HEMATOLOGY, 2019, 98 (03) : 691 - 703
[2] The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo
Eric Sanchez
Mingjie Li
Saurabh Patil
Camilia M. Soof
Jason D. Nosrati
Remy E. Schlossberg
Aleksandra Vidisheva
Edward J. Tanenbaum
Tara Hekmati
Brian Zahab
Cathy Wang
George Tang
Haiming Chen
James R. Berenson
[J]. Annals of Hematology, 2019, 98 : 691 - 703
[3] Effects of INCB052793, a Selective JAK1 Inhibitor, in Combination with Anti- Myeloma Agents on Human Multiple Myeloma (MM) In Vitro and In Vivo
Sanchez, Eric
Li, Mingjie
Wang, Cathy S.
Mehta, Puja
Tang, George
Chen, Haiming
Berenson, James
[J]. BLOOD, 2016, 128 (22)
[4] Anti-Myeloma Effects of the Selective JAK1 Inhibitor INCB052793 Using a Platform Study Utilizing the Lagκ-1A Multiple Myeloma Xenograft Model
Sanchez, Eric
Li, Mingjie
Wang, Cathy S.
Tanenbaum, Edward J.
Patil, Saurabh
Soof, Camilia
Hekmati, Tara
Schlossberg, Remy E.
Yashar, Moryel A.
Porter, Autumn L.
Tang, George Y.
Chen, Haiming
Berenson, James R.
[J]. BLOOD, 2017, 130
[5] Effects of INCB052793, a selective JAK1 inhibitor, in combination with standard of care agents in human multiple myeloma (MM) cell lines and xenograft models
Sanchez, Eric
Li, Mingjie
Wang, Cathy
Mehta, Puja
Tang, George
Chen, Haiming
Berenson, James R.
[J]. CANCER RESEARCH, 2016, 76
[6] A Phase 1/2 Study of the Oral Novel JAK1 Inhibitor INCB052793 As Monotherapy and in Combination with Standard Therapies in Patients with Advanced Hematologic Malignancies
Zeidan, Amer M.
Cook, Rachel J.
Bordoni, Rodolfo
Asatiani, Ekaterine
Zhou, Gongfu
Faivre, Thea
Byrne, Michael
Savona, Michael R.
[J]. BLOOD, 2017, 130
[7] Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
Saha, M. N.
Chen, Y.
Chen, M-H
Chen, G.
Chang, H.
[J]. BRITISH JOURNAL OF CANCER, 2014, 110 (09) : 2224 - 2231
[8] Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
M N Saha
Y Chen
M-H Chen
G Chen
H Chang
[J]. British Journal of Cancer, 2014, 110 : 2224 - 2231
[9] The BET inhibitor INCB054329 is synergistic with JAK1 inhibition in models of multiple myeloma
Stubbs, Matthew C.
Liu, Xuesong M.
Wen, Xiaoming
Li, Jun
Dostalik, Valerie
O'Connor, Sybil
Caulder, Eian
Favata, Margaret
Rupar, Mark
Li, Yu
Rumberger, Beth
Maduskuie, Thomas
Sparks, Richard
Falahatpisheh, Nikoo
Polam, Padmaja
Vaddi, Kris
Burn, Timothy
Combs, Andrew P.
Yao, Wenqing
Huber, Reid
Hollis, Gregory
Scherle, Peggy
Liu, Phillip C. C.
[J]. CANCER RESEARCH, 2015, 75
[10] The JAK inhibitor INCB20 induces antiproliferative and apoptotic effects in human myeloma cells in vitro and in vivo
Burger, R
Legouill, S
Tai, YT
Shringarpure, R
Podar, K
Catley, L
Tassone, P
Neri, P
Hideshima, T
Chauhan, D
Caulder, E
Vaddi, K
Neilan, CL
Gramatzki, M
Fridman, JS
Anderson, KC
[J]. BLOOD, 2005, 106 (11) : 938A - 938A

← 1 2 3 4 5 →